Wednesday, July 30, 2014 11:09:46 PM
Your great idea to release everything warts and all has a few issues with it in my eyes. As a company, we currently sell shares for cash. Your 'great' idea is for absolute honesty and for us to PR at the drop of a hat.
Your 'great idea' would likely send the stock price tumbling, not sure how 'agreeable' you would be then??
I'm smart enough to realise that this latest PR has negative implications but I'm grateful that Kim has painted it in a way that means plenty of investors will read it as positive (hence no sudden plummet). I'm smart enough to see that there's negatives but also optimistic enough to see the positive ("yeah we had issues but we've got them sorted and now we are FLYING").
Your suggestion is to announce the negative without announcing the solution in tandem. I'd rather you keep that suggestion locked away as I certainly wouldn't want Kim to take any notice of it.
On a final note, would love it if you humoured me and spent a little time digging on go the magical World Wide Web and find me some PRs from companies that have a completely truthful tone with plenty of negative and not an ounce of positive spin. There's a good reason why you'll have a hard time finding many of those.
Recent KBLB News
- Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend] • Edgar (US Regulatory) • 11/22/2023 09:31:54 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 11/16/2023 09:30:34 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/13/2023 09:43:51 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 09/11/2023 08:30:50 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 09/08/2023 04:15:15 AM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 09/01/2023 08:30:52 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2023 08:35:05 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM